The trials varied considerably in starting age (20 to 29 years), stopping age (38 to 64 years), and follow-up protocols
The trials varied considerably in starting age (20 to 29 years), stopping age (38 to 64 years), and follow-up protocols Cotesting vs Cytology Alone Four RCTs (N > 130,000 women) compared screening with cytology alone vs cotesting (cytology in combination with hrHPV testing): the NTCC Phase I trial in Italy, 28,32,34 Swedescreen in Sweden, 36,37 […]